Advertise here
Advertise here

Novartis back in Huntington’s with $1B licensing deal with PTC

Novartis has signed a licensing deal with PTC Therapeutics for an experimental Huntington’s disease treatment, with an upfront payment of $1 billion. The agreement also includes the potential for another $1.9 billion in payments based on hitting development, regulatory, and commercial milestones. Novartis CEO Vas Narasimhan stated that this deal aims to strengthen their neuroscience…

Read More

Education is essential for implementing the NHS workforce plan

Colin Macdougall and colleagues discuss the challenges facing the UK National Health Service, citing workforce shortages and a crisis in healthcare. The NHS published a long term workforce plan in 2023 with ambitious goals to address these issues, including increasing medical school places, general practitioner training places, nursing training places, and dentistry training places. The…

Read More

New Leukemia Txs, Fewer Blood Clots With GLP-1 Rxs

Groundbreaking studies on leukemia treatments and the effects of GLP-1 inhibitors on VTE risk will be presented at the ASH 2024 Annual Meeting. Research shows that adding blinatumomab to chemotherapy boosts disease-free survival in pediatric B-ALL patients, while eltrombopag is effective in treating severe pediatric ITP. Additionally, GLP-1 agonists may reduce the risk of VTE…

Read More

Depression May Trigger Severe Period Pain, Sleep Disturbances May Aggravate It: Study

A new study suggests that depression may actually trigger severe menstrual cramps, with sleep deprivation worsening their severity. Dysmenorrhea, or severe period pain, affects 15% of women and can be either primary or secondary. Research found a strong link between depression and primary dysmenorrhea in both European and East Asian populations, with sleep disturbances exacerbating…

Read More

Medicare Advantage fixes would regulate AI used to deny care

The Biden administration is pushing for Medicare to cover obesity drugs, but also proposing changes to private Medicare plans. The Centers for Medicare and Medicaid Services are suggesting technical and policy changes to Medicare Advantage and Part D plans for 2026. More than half of Medicare beneficiaries are enrolled in Medicare Advantage plans, but issues…

Read More

Gut transit time and pH shape microbiome individuality and dietary responses

A recent study published in Nature Microbiology investigated how gut transit time and pH affect variations in the human gut microbiome’s composition and metabolism. The study included 63 healthy participants and found significant variability in gut environment stability, with factors like stool moisture and pH influencing microbial composition and metabolic activity. Factors such as transit…

Read More

Which First-Line Treatments Are Most Cost-Effective?

A study evaluated the cost-effectiveness of different initial treatments for eosinophilic esophagitis (EoE), comparing proton pump inhibitor (PPI) therapy, swallowed topical corticosteroids (tCS), elimination diets, and the biologic dupilumab. Results showed that elimination diets were the most cost-effective option from a payer perspective, while PPI therapy was more cost-effective from a societal standpoint. Dupilumab would…

Read More

We’re reading about Medicare obesity coverage, a 340B analysis

The Biden administration is proposing Medicare and Medicaid coverage for weight loss drugs Wegovy and Zepbound, potentially costing $35 billion over a decade. Amgen’s obesity drug, MariTide, showed promising results with 20% weight loss in a Phase 2 study, leading to questions about its competitiveness. The results suggest MariTide could outperform other drugs like Wegovy…

Read More

HIV infections can be prevented—why some people act to protect themselves, and others don’t

The number of new HIV infections has decreased, but the impact on global health remains significant. In 2023, 1.3 million people acquired HIV, exceeding the target set by UNAids. Effective prevention methods like PrEp, condoms, vaginal rings, and injectables are available, but user decision-making plays a key role. A new framework called the decision cascade…

Read More

Neural connectivity predicts deep brain stimulation success in essential tremor

Groundbreaking research into thalamic connectivity is revolutionizing essential tremor treatment strategies, leading to more personalized and efficient deep brain stimulation (DBS) therapies. A recent study published in Brain highlights the intricate neural mechanisms involved in essential tremors, focusing on the cortical-thalamic-tremor network. By analyzing brain signals and tremor patterns, researchers identified specific connectivity patterns that…

Read More

Eating More Red Meat Could Increase Type 2 Diabetes Risk

Eating less red and processed meat may reduce the risk of developing type 2 diabetes and lower mortality for those with the disease, according to recent studies. High red meat intake has been associated with various health risks, including T2D and overall mortality. Studies suggest that reducing processed meat intake could prevent hundreds of thousands…

Read More

Biotech news from Roche, Amgen, Cassava

Stay updated on the latest science and politics in biotech with our newsletter. Adam Feuerstein is filling in for regular correspondents and reports that biotech companies are releasing all remaining news for the year before Thanksgiving, creating a hectic morning. The article is exclusive to STAT+ subscribers, offering in-depth analysis, newsletters, premium events, and news…

Read More

Mosquito-borne diseases are on the rise—here’s how collecting mozzies in your backyard can help science

Mosquitoes and mosquito-borne diseases are becoming more prevalent in Australia, with hundreds of types of mosquitoes posing health risks. Health authorities track mosquitoes to provide early warnings of disease risks, but citizen scientists are stepping in to help. The Mozzie Monitors program engages participants to monitor mosquito populations and contribute valuable data. By combining citizen…

Read More

Bacteria modify their ribosomes in response to the antibiotics

The research published in Nature Communications shows that bacteria can modify their ribosomes when exposed to antibiotics, potentially leading to antibiotic resistance. Escherichia coli was studied after exposure to streptomycin and kasugamycin, which target ribosomes to prevent protein production. The study found that the bacteria developed new ribosomes lacking chemical tags where antibiotics bind, making…

Read More

WeightWatchers combined with weight loss medications may alter alcohol consumption, study finds

A study by researchers at Henry Ford Health in collaboration with WeightWatchers International found that over 40% of individuals in a weight loss program who used popular weight loss medications decreased their alcohol consumption. Medications like bupropion and naltrexone were associated with the greatest reduction in alcohol use. However, adjusting for weight loss may have…

Read More

Recovery periods important to maintain the health and well-being of medical professionals

A study examined the psychobiological responses of Pre-Hospital Emergency Medical doctors and paramedics during high-fidelity training scenarios over two weeks. The research found that emergency situations trigger stress responses that are essential for dealing with threats, but repeated exposure to emergencies can lead to burnout. The study highlights the importance of recovery periods for maintaining…

Read More

Diet Matters in Prostate Cancer, but It’s Complicated

Recent studies have shown that diet plays a role in prostate cancer risk and progression. Diets like ultralow-carbohydrate, weight loss, omega-3 fatty acid supplementation, and pro- and anti-inflammatory diets have been linked to affecting prostate cancer risk. Studies have shown that diets adhering to the US government’s recommendations and plant-based diets may lower the risk…

Read More

Enhancing the efficacy of cell transplantation therapy for stroke or traumatic brain injury

Researchers have developed a technique to improve cell transplantation therapy for stroke or traumatic brain injury by using human induced pluripotent stem cell-derived brain organoids. The study, published in Stem Cells Translational Medicine, found that treatment with the growth factor progranulin enhanced the survival and engraftment of transplanted neurons. This priming agent improved axonal extension…

Read More

KIT’s 3ROCKIT 3R Center works towards developing methods to replace animal testing

3ROCKIT is a center at KIT that focuses on replacing animal testing with digital and technological solutions in healthcare. It follows a 6R principle to reduce, replace, refine, ensure robust experimental designs, register experiments, and publish negative results. Using AI and digital technologies, researchers create Virtual Human Twins for personalized medicine, simulate active ingredients and…

Read More

Debate Continues Over Prolonged Grief Disorder

Prolonged grief disorder (PGD) was added to the DSM-5-TR two years ago, sparking debate over pathologizing grief and setting specific timelines. PGD is characterized by intense and disabling yearning for a deceased person lasting over a year, requiring evaluation to prevent distress, poor health, and suicide. PGD diagnosis involves specific symptoms persisting for a month,…

Read More

New report urges guidelines for stem cell-based embryo models

The Nuffield Council on Bioethics in the UK recommends setting guidelines for stem cell research that mimics aspects of embryonic development. They suggest not using these models to start pregnancies or making them capable of feeling pain or awareness. Current models are not advanced enough for these outcomes, but researchers are continuously improving them. The…

Read More

Asthma: New UK guidelines signal “step change” in diagnosis and treatment

The new clinical guidelines recommend that combination treatment with an inhaled corticosteroid and formoterol should be the standard first-line treatment for asthma patients aged 12 and over, rather than prescribing short-acting β2 agonists like salbutamol alone. This approach, known as anti-inflammatory reliever therapy, aims to reduce inflammation and relieve symptoms to prevent hospital admissions and…

Read More

Africa’s making progress against HIV, but donor funds are drying up—what must change

Significant progress has been made in the fight against the HIV epidemic in the last two decades, particularly in Africa where access to treatment has increased and HIV-related deaths have declined. However, there is a lack of momentum globally, threatening the strides made. Challenges include dwindling funding, particularly in Sub-Saharan Africa, where most HIV cases…

Read More

COP29 outcomes fall short on climate health action

Experts from LSHTM found that agreements made at COP29 did not fully address the impacts of climate change on health. While progress was made in integrating health into the climate agenda, significant shortcomings remained. Richer countries agreed to provide $300 billion annually to poorer countries by 2035 to tackle climate change, falling short of the…

Read More

Community Factors Linked to Increased MCI Risk

A study involving 2830 older adults found that greater neighborhood disadvantage, exposure to air pollution, higher homicide rates, and reduced greenspace are associated with an increased risk for mild cognitive impairment (MCI). Factors such as the Area Deprivation Index (ADI), fine particulate matter exposure, homicide rates, greenspace, and schooling location were linked to MCI. The…

Read More

Synapticure Secures $25M To Scale Virtual Care for Neurodegenerative Diseases

Synapticure, a virtual care company focusing on neurodegenerative diseases, has raised $25 million in Series A funding to expand its services and partnerships. The Chicago-based company offers virtual access to neurologists, treatments, and care coordination services for diseases like Alzheimer’s, Parkinson’s, and ALS. The funding, led by B Capital, will be used to enhance AI-powered…

Read More

Four-in-ten first-time HIV diagnoses found late

In 2023, there was a 15% decrease in new HIV diagnoses in Ireland compared to pre-pandemic years, with a total of 911 cases reported. However, almost 40% of cases were diagnosed late, with 61% of cases found in people already aware of their HIV status. The number of first-time diagnoses has been increasing since the…

Read More
Advertise here
error: Content is protected !!